- Dr Udaya Seneviratne, Consultant Neurologist, General Hospital, Ratnapura, Sri Lanka
- Received 5 January 2000
- Accepted 19 April 2000
Guillain-Barré syndrome is an autoimmune disorder encompassing a heterogeneous group of pathological and clinical entities. Antecedent infections are thought to trigger an immune response, which subsequently cross reacts with nerves leading to demyelination or axonal degeneration. Both intravenous immunoglobulin treatment and plasma exchange have been found to be equally beneficial. Several factors are useful in predicting the outcome of these patients.